Artisight Secures $42 Million in Oversubscribed Series B Funding to Revolutionize Healthcare with AI

Share This Post

Key Highlights

  • Raised $42 million in an oversubscribed Series B funding round, with participation from strategic and client health system investors, including Series A investors like NVIDIA.
  • Artisight’s platform, designed by clinicians, integrates IoT sensors with deep learning for virtual nursing, reducing administrative burdens and improving patient outcomes.
  • Notable results include a 52% reduction in nursing overtime and 89% reduction in falls, as reported by client Northwestern Medicine.

Source: PR Newswire

Notable Quotes

  • “Our Series B round, which was oversubscribed by 2.4x, provides further validation of the results we have delivered for over 100 hospitals…” – Andrew Gostine, MD, MBA, Co-founder and CEO at Artisight
  • “We are just scratching the surface of what is possible with ambient intelligence—the best is yet to come.” – Andrew Gostine, MD, MBA, Co-founder and CEO at Artisight

SoH's Take

Artisight’s impressive Series B funding round marks a significant milestone in the realm of healthcare technology. With the substantial investment, Artisight is poised to further enhance its Smart Hospital Platform, which has already demonstrated remarkable efficiency improvements and cost savings in healthcare settings. The fusion of AI, IoT, and deep learning in a platform designed by clinicians for clinicians addresses the critical need for streamlined patient care and reduced administrative burden. Artisight’s commitment to innovation and its results-driven approach make it a standout in the industry, promising a future where technology and healthcare converge for better patient outcomes and satisfaction. This funding round not only endorses Artisight’s vision but also signals a transformative phase in healthcare technology, where ambient intelligence becomes a cornerstone in clinical settings.

More To Explore

Total
0
Share